
Tirzepatide
Dual GIP/GLP-1 receptor agonist studied for metabolic regulation and body weight research.
"Switched to Popular Peptides after a bad experience with a US supplier who couldn't provide proper documentation. Night ..."
Tirzepatide is a dual GIP and GLP-1 receptor agonist studied for its effects on glucose homeostasis and body weight regulation in research models. As a twincretin, it activates two complementary incretin pathways simultaneously.
Research has investigated its effects on insulin secretion, glucagon suppression, gastric emptying, and appetite regulation. It represents a significant advancement in the study of incretin-based metabolic therapies.
All Popular Peptides compounds are manufactured under strict GMP protocols and independently tested for purity and identity. Certificate of Analysis provided with every order.
⚠️ Research Use Only. This compound is intended for in vitro research and laboratory use only. Not for human or veterinary consumption.